In turn, BP up-regulated E-cadherin and down-regulated N-cadherin, so the result implicates that BP inhibit the migration in bladder cancer cells via the modulation of E-cadherin and N-cadherin. The gene discussed is CDH2; the disease is urinary bladder carcinoma.